FOZL fzl

Biopharmaceuticals

Biopharmaceuticals

Singapore's strong talent pool in technology, robust manufacturing capabilities, and thriving R&D ecosystem attract pharmaceutical and biotechnology companies to establish R&D and manufacturing facilities, serving patients globally and connecting with the growing Asian market.

A Growing Industry

 

A Leading Business Hub

Singapore, as a leading biomedical hub located in the heart of Asia, is the preferred location for companies to develop and manufacture new products to better meet Asia's healthcare needs. Businesses benefit from our pro-business environment, infrastructure, talent and innovation ecosystem, and our proximity to other countries and regions in Asia.

 

World-class Manufacturing Capabilities

Singapore is an ideal location for biopharmaceutical manufacturing plants, launching and producing numerous innovative products. Industry leaders such as Pfizer, Novartis, Sanofi, AbbVie and Amgen have global manufacturing centers in Singapore, producing a variety of products including active pharmaceutical ingredients, drug products and biopharmaceutical substances. Since 2014, we have also partnered with the industry to develop new talent training programs.

 

Innovation Ecosystem

Even as drug discovery and development models are changing due to regulatory changes and challenging R&D productivity, our broad and integrated research ecosystem continues to provide pharmaceutical companies with the ability to influence and create value. Here, companies can partner with key opinion leaders, research institutions, emerging biotech companies, and clinical and contract research organizations to rapidly advance pipeline assets.

S$4 billion in public sector research funding has been allocated to the health and biomedical sciences sector.

Contact Us

Learn how to help you successfully start your international journey.

Leave us a message